Methods & Compositions for the Activation of Gamma-delta T-cells
Country:
US
Docket No:
436313-000393
Publication Number:
10,428,350
Patent Expiry:
01/13/2037
Claims Scope:
Patent issued October 1, 2019.
Sequence Agnostic – Methods only
Methods of treating cancer by administering a composition comprising a therapeutic vector encoding at least one shRNA or miRNA that inhibits production of FDPS.
